Study of Plasma Copeptin as a Predictor of Diabetic Nephropathy in Type 2 Diabetic Patients

Study of Plasma Copeptin as a Diagnostic biomarker for Nephropathy in Type 2 Diabetes

Study of the Level of Copeptin in Patients with Diabetic Retinopathy

Copeptin: Promising Biomarker for Nephropathy in Type II Diabetes

Serum suPAR and Urinary Nephrin as Novel Sensitive and Specific Markers for Diabetic Nephropathy in Patients with Type 2 DM

Value of Serum Copeptin Estimation in the Diagnosis of Kidney Injury in Preeclampsia

Assessment of Serum and Urinary Adiponectin as Biomarkers in Type 2 Diabetic Patients with Diabetic Nephropathy

SERUM CHROMOGRANIN A AS EARLY BIOMARKER FOR DIAGNOSIS OF DIABETIC KIDNEY DISEASE IN TYPE 2 DIABETES MELLITUS

Assessment of copeptin levels in children with type 1 diabetes

Serum and Urine Neutrophil Gelatinase- Associated Lipocalin: As an Indicator for Early Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients